The gemcitabine HCl market is expected to witness significant growth during the forecast period. Varied R&D activities are contributing to the growth of the market. Growing cancer cases, especially in females such as breast and ovarian cancer, drives the gemcitabine HCl market. COVID-19 also had a major impact on the market growth.
Frequently Asked Questions
The market is segmented based on Global Gemcitabine HCl Market Segmentation, By Indication (Breast Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Bladder Cancer, Biliary Tract Cancer, Others), Route of Administration (Intravenous), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2032
.
The Global Gemcitabine Hcl Market size was valued at USD 749.73 USD Million in 2024.
The Global Gemcitabine Hcl Market is projected to grow at a CAGR of 7% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
